Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

por Folprecht, Gunnar, Hamann, Susanne, Schütte, Katharina, Trarbach, Tanja, Stoehlmacher-Williams, Jan, Ehninger, Gerhard
Publicado 2014

EGFR, FLT1 and Heparanase as Markers Identifying Patients at Risk of Short Survival in Cholangiocarcinoma

por Hoffmann, Andreas-Claudius, Goekkurt, Eray, Danenberg, Peter V., Lehmann, Sylvia, Ehninger, Gerhard, Aust, Daniela E., Stoehlmacher-Williams, Jan
Publicado 2013